Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

živilo za posebne zdravstvene namene - peroralna suspenzija - živilo za posebne zdravstvene namene 500 ml / 1 vrečica - maščobe, ogljikovi hidrati, proteini, minerali in vitamini, kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

živilo za posebne zdravstvene namene - peroralna suspenzija - živilo za posebne zdravstvene namene 500 ml / 1 vrečica - maščobe, ogljikovi hidrati, proteini, minerali in vitamini, kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

živilo za posebne zdravstvene namene - peroralna suspenzija - živilo za posebne zdravstvene namene 200 ml / 1 plastenka - maščobe, ogljikovi hidrati, proteini, minerali in vitamini, kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

živilo za posebne zdravstvene namene - peroralna suspenzija - živilo za posebne zdravstvene namene 200 ml / 1 plastenka - maščobe, ogljikovi hidrati, proteini, minerali in vitamini, kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

živilo za posebne zdravstvene namene - peroralna suspenzija - živilo za posebne zdravstvene namene 200 ml / 1 plastenka - maščobe, ogljikovi hidrati, proteini, minerali in vitamini, kombinacije

Evropska unija - slovenščina - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

živilo za posebne zdravstvene namene - peroralna suspenzija - živilo za posebne zdravstvene namene 200 ml / 1 plastenka - maščobe, ogljikovi hidrati, proteini, minerali in vitamini, kombinacije

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zdravilni obliž - zdravila s salicilno kislino

Evropska unija - slovenščina - EMA (European Medicines Agency)

ceva santé animale - torasemide - visoki strop diuretiki, sulfonamide, navaden - psi - za zdravljenje kliničnih znakov, povezanih z kongestivnega srčnega popuščanja pri psih, vključno z pljučni edem.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

huvepharma nv uitbreidingstraat 80 2600 antwerpen belgija proizvajalec odgovoren za sproščanje serij: biovet jsc 39 petar rakov str 4550 peshtera bolgarija 2 -